| Laparoscopic Versus Open Resection for Colorectal Liver Metastases The OSLO-COMET Randomized Controlled Trial |
99 |
| Benchmarking Complications Associated With Esophagectomy |
87 |
| The Southampton Consensus Guidelines for Laparoscopic Liver Surgery From Indication to Implementation |
83 |
| Oncological Benefits of Neoadjuvant Chemoradiation With Gemcitabine Versus Upfront Surgery in Patients With Borderline Resectable Pancreatic Cancer A Prospective, Randomized, Open-label, Multicenter Phase 2/3 Trial |
76 |
| Robot-assisted Minimally Invasive Thoracolaparoscopic Esophagectomy Versus Open Transthoracic Esophagectomy for Resectable Esophageal Cancer A Randomized Controlled Trial |
75 |
| Personalised Prehabilitation in High-risk Patients Undergoing Elective Major Abdominal Surgery: A Randomized Blinded Controlled Trial |
70 |
| ImmunoScore Signature A Prognostic and Predictive Tool in Gastric Cancer |
67 |
| Minimally Invasive Versus Open Distal Pancreatectomy (LEOPARD) A Multicenter Patient-blinded Randomized Controlled Trial |
66 |
| Artificial Intelligence in Surgery: Promises and Perils |
62 |
| An Educational Intervention Decreases Opioid Prescribing After General Surgical Operations |
61 |
| Disease-free Survival and Local Recurrence for Laparoscopic Resection Compared With Open Resection of Stage II to III Rectal Cancer Follow-up Results of the ACOSOG Z6051 Randomized Controlled Trial |
56 |
| Patterns, Timing, and Predictors of Recurrence Following Pancreatectomy for Pancreatic Ductal Adenocarcinoma |
53 |
| Laparoscopic Heller Myotomy Versus Peroral Endoscopic Myotomy (POEM) for Achalasia A Systematic Review and Meta-analysis |
53 |
| Predictors of Resectability and Survival in Patients With Borderline and Locally Advanced Pancreatic Cancer who Underwent Neoadjuvant Treatment With FOLFIRINOX |
50 |
| Short-term Outcomes of a Multicenter Randomized Controlled Trial Comparing Laparoscopic Distal Gastrectomy With D2 Lymphadenectomy to Open Distal Gastrectomy for Locally Advanced Gastric Cancer (KLASS-02-RCT) |
49 |
| Opioid Use After Discharge in Postoperative Patients A Systematic Review |
49 |
| Biomarker-guided Intervention to Prevent Acute Kidney Injury After Major Surgery The Prospective Randomized BigpAK Study |
49 |
| Incidence and Risk Factors for Anastomotic Failure in 1594 Patients Treated by Transanal Total Mesorectal Excision Results From the International TaTME Registry |
48 |
| Robotic Versus Laparoscopic Minimally Invasive Surgery for Rectal Cancer: A Systematic Review and Meta-analysis of Randomized Controlled Trials |
48 |
| Comparison of Perioperative Outcomes Between Laparoscopic and Open Approach for Pancreatoduodenectomy The PADULAP Randomized Controlled Trial |
48 |
| No Surgical Innovation Without Evaluation Evolution and Further Development of the IDEAL Framework and Recommendations |
46 |
| Bariatric Surgery and the Risk of Cancer in a Large Multisite Cohort |
45 |
| Difficulty of Laparoscopic Liver Resection: Proposal for a New Classification |
44 |
| Survival in Locally Advanced Pancreatic Cancer After Neoadjuvant Therapy and Surgical Resection |
42 |
| Multimodal Patient Blood Management Program Based on a Three-pillar Strategy A Systematic Review and Meta-analysis |
42 |
| ALPPS Improves Resectability Compared With Conventional Two-stage Hepatectomy in Patients With Advanced Colorectal Liver Metastasis Results From a Scandinavian Multicenter Randomized Controlled Trial (LIGRO Trial) |
41 |
| Minimally Invasive versus Open Distal Pancreatectomy for Ductal Adenocarcinoma (DIPLOMA) |
40 |
| The Impact of Positive Resection Margins on Survival and Recurrence Following Resection and Adjuvant Chemotherapy for Pancreatic Ductal Adenocarcinoma |
39 |
| Targeted Muscle Reinnervation Treats Neuroma and Phantom Pain in Major Limb Amputees A Randomized Clinical Trial |
39 |
| Defining and Predicting Early Recurrence in 957 Patients With Resected Pancreatic Ductal Adenocarcinoma |
38 |
| Robot-assisted Versus Laparoscopic Surgery for Rectal Cancer A Phase II Open Label Prospective Randomized Controlled Trial |
38 |
| Disease-free Survival and Local Recurrence After Laparoscopic-assisted Resection or Open Resection for Rectal Cancer The Australasian Laparoscopic Cancer of the Rectum Randomized Clinical Trial |
37 |
| Learning Curve and Associated Morbidity of Minimally Invasive Esophagectomy A Retrospective Multicenter Study |
37 |
| The Systemic-immune-inflammation Index Independently Predicts Survival and Recurrence in Resectable Pancreatic Cancer and its Prognostic Value Depends on Bilirubin Levels A Retrospective Multicenter Cohort Study |
36 |
| Microsatellite Instability and Programmed Cell Death-Ligand 1 Expression in Stage II/III Gastric Cancer Post Hoc Analysis of the CLASSIC Randomized Controlled study |
34 |
| Results of a Prospective, Multicenter Initiative Aimed at Developing Opioid-prescribing Guidelines After Surgery |
34 |
| Alternative Fistula Risk Score for Pancreatoduodenectomy (a-FRS) Design and International External Validation |
33 |
| Sarcopenia and Postoperative Complication Risk in Gastrointestinal Surgical Oncology A Meta-analysis |
32 |
| Tumor-infiltrating Neutrophils is Prognostic and Predictive for Postoperative Adjuvant Chemotherapy Benefit in Patients With Gastric Cancer |
32 |
| Effect of Hospital Volume on In-hospital Morbidity and Mortality Following Pancreatic Surgery in Germany |
31 |
| Laparoscopy-assisted versus Open D2 Distal Gastrectomy for Advanced Gastric Cancer Results From a Randomized Phase II Multicenter Clinical Trial (COACT 1001) |
31 |
| Oncological and Survival Outcomes in Watch and Wait Patients With a Clinical Complete Response After Neoadjuvant Chemoradiotherapy for Rectal Cancer A Systematic Review and Pooled Analysis |
30 |
| Effects of Intraoperative Fluid Management on Postoperative Outcomes: A Hospital Registry Study |
30 |
| Assessment of Sarcopenia as a Predictor of Poor Outcomes After Esophagectomy in Elderly Patients With Esophageal Cancer |
29 |
| Enhanced Recovery After Surgery for Noncolorectal Surgery?: A Systematic Review and Meta-analysis of Major Abdominal Surgery |
29 |
| US FDA Breast Implant Postapproval Studies Long-term Outcomes in 993 Patients |
28 |
| Comparing Short-term and Oncologic Outcomes of Minimally Invasive Versus Open Pancreaticoduodenectomy Across Low and High Volume Centers |
28 |
| Complications in Postmastectomy Breast Reconstruction: One-year Outcomes of the Mastectomy Reconstruction Outcomes Consortium (MROC) Study |
28 |
| A New Scoring System to Predict Recurrent Disease in Grade 1 and 2 Nonfunctional Pancreatic Neuroendocrine Tumors |
28 |
| Liver Transplantation and Hepatic Resection can Achieve Cure for Hepatocellular Carcinoma |
28 |
